GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XBUL:EVT) » Definitions » 3-Year Share Buyback Ratio

Evotec SE (XBUL:EVT) 3-Year Share Buyback Ratio : -0.20% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Evotec SE 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Evotec SE's current 3-Year Share Buyback Ratio was -0.20%.

The historical rank and industry rank for Evotec SE's 3-Year Share Buyback Ratio or its related term are showing as below:

XBUL:EVT' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -20.1   Med: -3.9   Max: -0.2
Current: -0.2

During the past 13 years, Evotec SE's highest 3-Year Share Buyback Ratio was -0.20%. The lowest was -20.10%. And the median was -3.90%.

XBUL:EVT's 3-Year Share Buyback Ratio is ranked better than
69.33% of 675 companies
in the Drug Manufacturers industry
Industry Median: -2.2 vs XBUL:EVT: -0.20

Competitive Comparison of Evotec SE's 3-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evotec SE's 3-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Evotec SE's 3-Year Share Buyback Ratio falls into.


;
;

Evotec SE 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Evotec SE (XBUL:EVT) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Evotec SE 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Evotec SE's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Evotec SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XBUL:EVT) » Definitions » 3-Year Share Buyback Ratio
Comparable Companies
FRA:DMP FRA:APPH XTER:B8FK ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM UTHR BOM:500124
Traded in Other Exchanges
EVO:USA 1EVT:Italy EVTd:UK 0IRF:UK EVT:Germany EVT:Germany EVT:Germany EVT:Germany EVTA:Germany EVT:Austria
Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Website
https://www.evotec.com
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.